1. Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nature reviews. Cardiology, 2019,16(4):203–212
2. Bayes-Genis A, de Antonio M, Galán A, et al. Combined use of high-sensitivity st2 and ntprobnp to improve the prediction of death in heart failure. Eur J Heart Fail, 2012,14(1):32–38
3. Villacorta H, Maisel AS. Soluble st2 testing: a promising biomarker in the management of heart failure. Arq Bras Cardiol, 2016,106(2):145–152
4. Bi J, Garg V, Yates AR. Galectin-3 and sst2 as prognosticators for heart failure requiring extracorporeal life support: jack n’ jill. Biomolecules (Basel, Switzerland), 2021,11(2):166
5. Daniels LB, Clopton P, Iqbal N, et al. Association of st2 levels with cardiac structure and function and mortality in outpatients. Am Heart J, 2010,160(4):721–728